Pressure ulcers, also known as bed sores, are injuries to the skin and underlying tissues that usually occur over a bony prominence as a result of continued pressure or friction. Pressure ulcers treatments aim to promote healing and prevent further damage through regular dressing changes, wound cleansing, and offloading pressure from affected areas. Products used in pressure ulcers treatment include wound care dressings, wound cleansers, debridement agents, growth factors, skin grafts, and therapeutic beds and mattresses.
The global Pressure Ulcers Treatment Market is estimated to be valued at Us$ 5247.86 Mn in 2023 and is expected to exhibit a CAGR Of 4.8% over the forecast period 2023 To 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing prevalence of pressure ulcers worldwide remains a key driver of growth in the pressure ulcers treatment market. It is estimated that 2.5 million people in the United States suffer from pressure ulcers annually. The condition is most common among elderly individuals residing in long-term care facilities as well as among patients who are immobilized or have impaired mobility owing to various medical reasons. Research conducted in Europe and North America further suggests that the annual incidence of pressure ulcers in hospitals and nursing homes is between 3-10% of all patients. The substantial and growing prevalence of patients at risk of developing pressure ulcers has led to rising adoption of advanced treatment products designed to effectively manage wounds and promote healing.
Segment Analysis
The global pressure ulcers treatment market is dominated by the devices sub-segment owing to the growing demand for advanced wound care products. The pressure ulcer devices segment accounted for the major market share of nearly 50% in 2023 due to the increasing adoption of technically advanced therapies like negative pressure wound therapy (NPWT), wound dressings and hyperbaric oxygen therapy. These advanced devices aid faster wound healing and prevent further infections.
Key Takeaways
The Global Pressure Ulcers Treatment Market Demand is expected to witness high growth over the forecast period. Rising cases of chronic conditions like diabetes, obesity and bedridden population due to stroke, paralysis and other disorders have augmented the risk of developing pressure ulcers. This has driven the demand for pressure ulcer prevention and treatment.
The global Pressure Ulcers Treatment Market is estimated to be valued at US$ 5247.86 Mn in 2023 and is expected to exhibit a CAGR of 4.8% over the forecast period 2023 to 2030.
Regional analysis
North America held the major share of over 35% in the global market in 2023 owing to the availability of advanced wound care facilities and favorable reimbursement policies in countries like the US and Canada. Asia Pacific is anticipated to showcase the fastest growth over the forecast period due to the rising patient pool affected by high blood pressure, diabetes and obesity in developing nations like India and China.
Key players
Key players operating in the pressure ulcers treatment market are Emergent Biosolutions Inc., SIGA Technologies Inc., Bavarian Nordic A/S, Elusys Therapeutics Inc., Ichor Medical Systems Inc., Amgen Inc., Cleveland BioLabs Inc., Dynavax Technologies Corporation, Alnylam Pharmaceuticals Inc., and XOMA Corporation.
Get more insights on this topic :
Comments
0 comment